Ergoteles’s Bio Green Med Solution Inc BGMS Stock Holding History

Ergoteles’s Portfolio BGMS Stock Details BGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7	Closed	-$17.3K	–	1359
2022 Q4	$17.3K	Buy	+7	New	+$25.8K	﹤0.01%	1351

Other funds holding BGMS

SSA

Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

McIlrath & Eck Arlington, Washington $1.35B AUM 15.78% 1-Year Est. Return

Ergoteles's BGMS Position: Q1 2023 in Review

Ergoteles sold out of Bio Green Med Solution Inc (BGMS) in Q1 2023, closing a stake of 7 shares — an estimated $17.3K sold.

Ergoteles first reported a position in BGMS in Q4 2022 and held it in 1 quarter. The position peaked at $17.3K in Q4 2022. 21 funds tracked by Wall St. Rank hold BGMS as of Q1 2023.

Ergoteles reported no remaining Bio Green Med Solution Inc position as of Q1 2023 after selling out during the quarter.
Ergoteles sold 7 Bio Green Med Solution Inc shares in Q1 2023, an estimated $17.3K.
Ergoteles first reported a position in Bio Green Med Solution Inc in Q4 2022 and held it in 1 quarter.
Ergoteles's Bio Green Med Solution Inc position peaked at $17.3K in Q4 2022.
21 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q1 2023.

Based on Ergoteles's 13F filing for Q1 2023, filed 10 May 2023.